Safe Use Symposium: A Focus on Reducing Preventable Harm from Drugs in the Outpatient Setting
The Food and Drug Administration's (FDA) Center for Drug Evaluation and Research, Professional Affairs and Stakeholder Engagement Staff (PASES), is hosting a one day public symposium entitled “Safe Use Symposium: A Focus on Reducing Preventable Harm from Drugs in the Outpatient Setting.” The purpose of this symposium is to discuss sources of preventable harm from drugs in the outpatient setting, and to stimulate the exchange of ideas among thought leaders on interventions to reduce preventable harms and how these interventions can be studied.
June 15, 2017
8:00 a.m. to 4:00 p.m.
FDA’s White Oak campus
10903 New Hampshire Avenue
Building 31 (The Great Room C)
Silver Spring, MD 20903.
To register for the public workshop, please visit the following website https://www.eventbrite.com/e/safe-use-symposium-a-focus-on-outpatient-preventable-adverse-drug-events-tickets-32893862428
Christine Lee, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Avenue., Silver Spring, MD 20993-0002, (240)-402-4228, Email: CDERSafeUseInitiative@fda.hhs.gov